Artificial Intelligence (AI) in Radiology

Global Artificial Intelligence (AI) in Radiology Market to Reach US$13.5 Billion by 2030

The global market for Artificial Intelligence (AI) in Radiology estimated at US$2.4 Billion in the year 2024, is expected to reach US$13.5 Billion by 2030, growing at a CAGR of 33.5% over the analysis period 2024-2030. Chest Imaging, one of the segments analyzed in the report, is expected to record a 28.8% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Colonoscopy segment is estimated at 37.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$650.3 Million While China is Forecast to Grow at 42.7% CAGR

The Artificial Intelligence (AI) in Radiology market in the U.S. is estimated at US$650.3 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 42.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 27.6% and 29.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.3% CAGR.

Global Artificial Intelligence (AI) in Radiology Market – Key Trends & Drivers Summarized

Why Is AI Transforming the Role of Radiologists and Diagnostic Accuracy in Medical Imaging?

Artificial Intelligence is revolutionizing radiology by enhancing the ability of clinicians to detect, interpret, and act upon complex medical images with unprecedented accuracy and speed. Radiology has long been central to diagnosing a broad range of conditions, including cancers, neurological disorders, musculoskeletal injuries, and cardiovascular diseases. However, traditional interpretation is time-intensive, and even experienced radiologists can occasionally miss subtle abnormalities due to human fatigue or cognitive overload. AI addresses these challenges by applying advanced image recognition algorithms that can detect minute patterns in X-rays, CT scans, MRIs, and mammograms, often flagging findings invisible to the human eye. Deep learning systems can be trained on millions of annotated images, enabling them to identify early-stage tumors, classify tissue anomalies, and distinguish between benign and malignant growths with high confidence. These AI tools do not replace radiologists but augment their capabilities, allowing them to focus more on complex cases and clinical decision-making. Moreover, AI can prioritize urgent cases by triaging image queues, ensuring that critical findings like brain hemorrhages or pulmonary embolisms are reviewed first. The integration of AI into radiology also improves consistency and standardization, reducing variability across different practitioners and institutions. Automated report generation and structured data output enhance workflow efficiency, documentation accuracy, and communication with other departments. As the volume of diagnostic imaging continues to rise globally, driven by aging populations and expanded access to healthcare, AI is becoming essential in maintaining quality care and timely diagnoses. Its impact is not limited to hospitals; outpatient clinics, teleradiology services, and mobile health units are also benefiting from AI’s scalable capabilities, making it a transformative force in medical imaging.

How Are Technological Advancements Powering AI Algorithms in Radiological Applications?

The evolution of AI in radiology is being propelled by rapid advancements in deep learning, neural networks, and computational infrastructure that make it possible to process vast quantities of imaging data in real time. Convolutional neural networks (CNNs) have become a cornerstone of AI in radiology due to their unmatched ability to analyze pixel-level data across multiple image modalities and deliver highly accurate predictions. These networks are trained using extensive datasets containing diverse patient demographics, disease types, and imaging parameters, improving their generalizability and diagnostic precision. Moreover, the availability of annotated medical imaging repositories and collaborations between hospitals and AI companies have accelerated model development and validation. Innovations in cloud computing and edge processing allow AI systems to perform complex computations either remotely or directly within imaging devices, minimizing latency and enabling real-time analysis. AI platforms are also becoming increasingly multimodal, combining imaging data with electronic health records, lab reports, and genomic information to deliver more context-aware insights. Natural language processing (NLP) is being used to extract relevant clinical data from radiology reports, enhancing diagnostic correlations and follow-up recommendations. Furthermore, explainable AI models are gaining traction, providing visual heatmaps and confidence scores that help radiologists understand the rationale behind the AI’s findings, which is critical for clinical trust and regulatory approval. Integration with Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) allows seamless deployment within existing clinical workflows. These technological innovations are not only increasing diagnostic performance but also ensuring that AI tools are adaptable, interpretable, and compatible with the rapidly evolving landscape of precision medicine and patient-centered care.

How Are Clinical Workflows, Reimbursement Models, and Regulatory Frameworks Shaping Adoption?

The adoption of AI in radiology is being shaped by a complex interplay of clinical workflow integration, reimbursement dynamics, and regulatory oversight. For AI tools to deliver tangible benefits, they must fit seamlessly into the daily routines of radiologists without introducing friction or inefficiencies. This requires intuitive interfaces, interoperability with existing systems like PACS, and minimal training time for clinical staff. Many AI vendors are focusing on creating plug-and-play solutions that can be deployed without major infrastructure changes. In parallel, reimbursement structures are evolving to support the use of AI in diagnostic processes. In some regions, insurers and government health programs are beginning to recognize AI-assisted interpretation as a reimbursable service, particularly for screenings such as mammography and lung cancer detection where early diagnosis significantly reduces long-term treatment costs. Regulatory bodies such as the U.S. FDA, European Medicines Agency, and local health authorities play a crucial role in setting safety and efficacy standards for AI medical devices. These agencies have begun to issue tailored guidelines for AI-based tools, covering aspects like continuous learning, data privacy, algorithm transparency, and clinical validation. The introduction of software as a medical device (SaMD) classifications has also facilitated the approval process for AI solutions. Clinical studies demonstrating improved diagnostic performance, reduced error rates, or increased throughput are key to gaining both regulatory clearance and physician confidence. Educational programs and awareness campaigns are also being developed to train radiologists in AI literacy, ensuring that users can interpret outputs critically and integrate them into clinical decision-making. Together, these efforts are creating a supportive environment for AI adoption that prioritizes clinical value, patient outcomes, and long-term sustainability in healthcare delivery.

What Is Driving the Accelerated Growth of the AI in Radiology Market Across the Globe?

The growth in the AI in radiology market is driven by a convergence of critical healthcare needs, technological advancements, and demographic shifts that are reshaping diagnostic medicine on a global scale. One of the most prominent drivers is the global rise in chronic diseases such as cancer, cardiovascular disorders, and neurological conditions, all of which require timely and accurate imaging for diagnosis and treatment planning. The increasing use of imaging modalities in routine health assessments and emergency care has led to a surge in radiology workloads, creating a need for tools that can enhance productivity without compromising accuracy. AI meets this need by automating routine image assessments, prioritizing critical findings, and supporting early disease detection. Additionally, the growing shortage of radiologists, particularly in rural and underserved areas, is prompting healthcare providers to adopt AI solutions that can extend diagnostic services to remote populations through teleradiology platforms. International investments in digital health infrastructure and smart hospitals are further accelerating the deployment of AI-powered radiology systems. Government-led initiatives to promote AI in healthcare, such as innovation grants, pilot programs, and national AI strategies, are also catalyzing market expansion. The commercialization of AI solutions by medtech companies, supported by strategic partnerships with hospitals and research institutions, is driving product availability and market penetration. As AI tools prove their value in improving diagnostic quality, reducing turnaround times, and lowering healthcare costs, their adoption is expanding across hospitals, imaging centers, and outpatient clinics worldwide. These factors, combined with growing confidence in the clinical reliability of AI systems, are propelling the radiology AI market forward, positioning it as a key enabler of more precise, efficient, and accessible diagnostic care in the years to come.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence (AI) in Radiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Radiology Type (Chest Imaging, Colonoscopy, Mammography, Head Imaging); Technique (X-rays, Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, Ultrasound, Other Techniques); Application (Computer Aided-Diagnostic Application, Computer Aided-Detection Application, Quantitative Analysis Tools Application, Clinics Detection Support Application)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• Aidoc
• AliveCor
• Arterys
• BeamAI
• Butterfly Network
• Cerebra
• Clario
• Enlitic
• eRad Systems
• Fovia Imaging
• IBM Watson Health
• Infervision
• KenSci
• Lunit
• Mediview
• Nanox AI
• RadiAnt DICOM Viewer
• Zebra Medical Vision
• Qure.ai
• Viz.ai

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher. Show more